Qing Tang
- Cancer Research top 1%
- Cancer-related molecular mechanisms research 22
- MicroRNA in disease regulation 18
- Molecular Biology top 5%
- Circular RNAs in diseases 14
- RNA modifications and cancer 13
- Natural product bioactivities and synthesis 12
- Epigenetics and DNA Methylation 10
- FOXO transcription factor regulation 7
- Metabolism, Diabetes, and Cancer 6
- Molecular Medicine top 5%
- Toxicology top 5%
- Immunology top 10%
- Journals
- SHILAP Revista de lepidopterología (1 paper)PLoS ONE (1 paper)Hepatology (1 paper)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Qing Tang
114 papers receiving 2.8k citations
Peers
Comparison fields: 5 of 117
- Cancer Research 1.1k
- Molecular Biology 1.9k
- Molecular Medicine 86
- Toxicology 55
- Immunology 320
Countries citing papers authored by Qing Tang
This map shows the geographic impact of Qing Tang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qing Tang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qing Tang more than expected).
Fields of papers citing papers by Qing Tang
This network shows the impact of papers produced by Qing Tang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qing Tang. The network helps show where Qing Tang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Qing Tang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 10 | |
| 4 | 2024 | 6 | |
| 5 | 2024 | 18 | |
| 6 | 2024 | 7 | |
| 7 | 2023 | 11 | |
| 8 | 2023 | 8 | |
| 9 | 2023 | 14 | |
| 10 | 2023 | 33 | |
| 11 | 2023 | 6 | |
| 12 | 2022 | 16 | |
| 13 | 2021 | 16 | |
| 14 | 2021 | 8 | |
| 15 | 2021 | 10 | |
| 16 | 2017 | 66 | |
| 17 | 2015 | 31 | |
| 18 | 2015 | 38 | |
| 19 | [Epidemiological study on the association between obesity with metabolic syndrome in obese children and adolescents of Nanning city, Guangxi]. | 2011 | 4 |
| 20 | 2008 | 14 |
About Qing Tang
Qing Tang is a scholar working on Cancer Research, Molecular Biology and Pharmacology, having authored 124 papers that have together received 2.9k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (22 papers), MicroRNA in disease regulation (18 papers), Circular RNAs in diseases (14 papers), RNA modifications and cancer (13 papers), Natural product bioactivities and synthesis (12 papers), Epigenetics and DNA Methylation (10 papers), FOXO transcription factor regulation (7 papers) and Metabolism, Diabetes, and Cancer (6 papers). The work is most often cited by research in Cancer Research (1.1k citations), Molecular Biology (1.9k citations) and Molecular Medicine (86 citations). Qing Tang has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Swei Sunny Hann, Jingjing Wu, Heng Fan, Xingxing Liu, Fang Zheng, Lijun Yang, Zhexing Shou, Fang Zheng, Wanyin Wu and Shunyu Zhao. Their work appears in journals such as SHILAP Revista de lepidopterología, PLoS ONE and Hepatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.